This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Tadalafil

ADCIRCA, CIALIS – Eli Lilly Canada Inc. (NOC Search)

Patents:

• 2181377: MYLAN, COBALT, TEVA, DOMINION, RIVA, PHARMASCIENCE, APOTEX
• 2226784: PHARMASCIENCE, RIVA, PHARMASCIENCE, APOTEX, COBALT, TEVA, MYLAN, DOMINION
• 2307101: APOTEX, COBALT, PHARMASCIENCE
• 2371684: ACTAVIS, RIVA, AURO, PRO DOC, JAMP, MYLAN, , RIVA, PHARMASCIENCE, RANBAXY, MINT, COBALT, TEVA, APOTEX, PHARMASCIENCE
• 2379948: PHARMASCIENCE, APOTEX, COBALT, TEVA, MINT, RANBAXY, , MYLAN, PRO DOC, JAMP, AURO, RIVA, ACTAVIS
• 2380087: COBALT, TEVA, MYLAN, APOTEX
• 2412594: APOTEX
• 2492540: RANBAXY, MINT, TEVA, APOTEX, PHARMASCIENCE, AURO, RIVA, ACTAVIS, JAMP, PRO DOC, MYLAN,

Unknown/Other

• Infringement – T-1630-16 – T-1636-16

ACTAVIS

• Infringement – T-1639-16

APOTEX

• Infringement – T-1632-16 (2019 FC 884, 2020 FC 814, 2023 FC 783, 2023 FC 3)
• PM(NOC) – A-330-15 (2016 FCA 267) – T-1597-13 – T-1598-13 (2015 FC 1165, 2015 FC 875) – T-1599-13 (2015 FC 1016, 2015 FC 1092, 2015 FC 1167) – T-1600-13 – T-169-13 – T-171-13 – T-172-13 – T-173-13 – T-2021-12
• Appeal – A-234-20 (2021 FCA 126, 2023 FCA 125) – A-239-20 – A-244-22 (2024 FCA 72) – A-273-21
• Section 8 – T-935-16

AURO

• Infringement – T-1628-16

COBALT

• PM(NOC) – T-966-13 – T-967-13 – T-968-13 – T-969-13 – T-970-13

DOMINION

• PM(NOC) – T-1101-16

JAMP

• Infringement – T-1626-16

MINT

• Infringement – T-1633-16

MYLAN

• Appeal – A-120-15 – A-139-15 (2015 FCA 286) – A-237-20 (2021 FCA 128) – A-269-21
• Infringement – T-1627-16 (2020 FC 816, 2023 FC 780, 2023 FC 13)
• PM(NOC) – A-47-15 (2016 FCA 119) – T-294-13 – T-295-13 – T-296-13 (2015 FC 17) – T-298-13 (2015 FC 125) – T-299-13 (2015 FC 178)

PHARMASCIENCE

• Infringement – T-1623-16 (2023 FC 779)
• PM(NOC) – T-2535-14 – T-2536-14 – T-2537-14 – T-2538-14

PHARMASCIENCE, RIVA

• Appeal – A-236-20 (2021 FCA 127)

PRO DOC

• Other – T-1637-16

RANBAXY

• Infringement – T-1638-16

RIVA

• PM(NOC) – T-877-16
• Infringement – T-1624-16

RIVA, PHARMASCIENCE

• Appeal – A-267-21

TEVA

• Infringement – T-1631-16 (2023 FC 9, 2023 FC 782, 2022 FC 1398)
• PM(NOC) – T-847-14 – T-848-14 – T-849-14 – T-850-14
• Appeal – A-238-20 (2021 FCA 129) – A-268-21

---

Return to the Patented Medicine Litigation page.